Dr. Hommer zum Nachlesen


The status of glaucoma diagnostics and care in Europe in 2015: a European survey.

Holló G, Hommer A.; Eur J Ophthalmol. 2015 Oct 30:0. doi: 10.5301/ejo.5000699. [Epub ahead of print]


Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma.

Hommer A, Hubatsch DA, Cano-Parra J; J Ophthalmol. 2015;2015:131970. doi: 10.1155/2015/131970. Epub 2015 Oct 1.


A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension;

A. Stevens; M. Iliev, L. de Jong, I. Grobeiu; A. Hommer; Clinical Ophthalmology 2016:10 1–7


The status of glaucoma diagnostics and care in Europe in 2015: a European survey.

Holló G, Hommer A., for the Delivery of Glaucoma Care Committee of the European Glaucoma Society; Eur J Ophthalmol 2016; 26 (3): 216-220


A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension

A. Stevens; M. Iliev, L. de Jong, I. Grobeiu; A. Hommer; Clinical Ophthalmology 2016:10 1–7


Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma.

Hommer A, Hubatsch DA, Cano-Parra J.; J Ophthalmol. 2015;2015:131970. doi: 10.1155/2015/131970. Epub 2015 Oct 1.


Efficacy, Safety and tolerability of Preservative – Free Fixed Combination of Tafluprost 0,0015%/Timolol 0,5% Versus Concommitant Use of the Ingredients.
Hollo G, Hommer A.;  2014: Journal of Ocular Pharmacology and Therapeutics


„Schlaglicht Augenheilkunde“: Glaukom
Herausgeber. Carl Erb, Thieme Verlag 2014 ISBN: 978-3-13-200201-2


Role of nitric oxide in optic nerve head blood flow regulation during isometric exercise in healthy humans.
Schmidl D, Boltz A, Kaya S, Lasta M, Pemp B, Fuchsjager-Mayrl G, Hommer A, Garhofer G, Schmetterer L. Invest Ophthalmol Vis Sci. 2013 Mar 15;54(3):1964-70.


Preservative-free treatment in glaucoma: who, when, and why.
Stalmans I, Sunaric Mégevand G, Cordeiro MF, Hommer A, Rossetti L, Goñi F, Heijl A, Bron A. Eur J Ophthalmol. 2013 Mar 7;23(4)


A double-masked randomized crossover study comparing the effect of latanoprost/timolol and brimonidine/timolol fixed combination on intraocular pressure and ocular blood flow in patients with primary open-angle glaucoma or ocular hypertension.
Hommer A, Sperl P, Resch H, Popa-Cherecheanu A, Qiao C, Schmetterer L, Garhöfer G: J Ocul Pharmacol Th 2012, 28(6); 569-75


Correlation of optic disc morphology and ocular perfusion parameters in patients with primary open angle glaucoma.
Resch H, Schmidl D, Hommer A, Rensch F, Jonas JB, Fuchsjäger-Mayrl G, Garhöfer G, Vass C, Schmetterer L: Acta Opthalmol 2011 May 23


12. März 2011 Weltglaukom-Tag 6.–12. März 2011 Weltglaukom-Woche.
Hommer A., Mistlberger A. Spektrum der Augenheilkunde April 2011, Volume 25, Issue 1, p 58


Role of fixed combinations in the management of open-angle glaucoma.
Hommer A. Expert Rev Pharmacoecon Outcomes Res. 2011 Feb;11(1):91-9. Review


Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost.
Hommer A, Kimmich F. Clin Ophthalmol. 2011;5:623-31


Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination
Centofanti M, Oddone F, Gandolfi S, Hommer A, Boehm A, Tanga L, Sangermani C, Sportelli V, Haustein M, Manni G, Rossetti L. Am J Ophthalmol. 2010 Oct;150(4):575-80


IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma.
Hommer A, Mohammed Ramez O, Burchert M, Kimmich F. Curr Med Res Opin. 2010 Aug;26(8):1905-13


Effect of dorzolamide and timolol on ocular pressure – blood flow relationship in patients with primary open angel glaucoma and ocular hypertension.
Fuchsjäger-Mayrl G, Georgopoulos M, Hommer A, Weigert G, Pemp B, VassC, Garhöfer G, Schmetterer L: Invest Ophth Vis Sci 2010, 51(3): 1289-1296


Retrobulbar blood flow velocities in open angle glaucoma and their association with mean arterial blood pressure.
Garhöfer G, Fuchsjäger-Mayrl G, Vass C, Pemp B, Hommer A, Schmetterer L: Invest Ophth Vis Sci 2010, 51(12): 6652-6657


IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma
Hommer A, Ramez O, Burchert M,Kimmich F: Current Medical Research & Opinion Vol. 26, No. 8, 2010, 1905–1913


Effect of dorzolamide and timolol on ocular pressure – blood flow relationship in patients with primary open angel glaucoma and ocular hypertension
Fuchsjäger-Mayrl G, Georgopoulos M, Hommer A, Weigert G, Pemp B, VassC, Garhöfer G, Schmetterer L:. Invest Ophth Vis Sci 2009 Oct 22


Behauptungen über Glaukom: Beurteilung und Bewertung durch amerikanische Glaukomexperten und österreichische AugenfachärztInnen – ein Vergleich.
Faschinger Ch. Eberle C., Hommer A. Spektrum der Augenheilkunde August 2009, Volume 23, Issue 4, pp 270-276


Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects.
Resch H, Karl K, Weigert G, Wolzt M, Hommer A, Schmetterer L, Garhöfer G:. Invest Ophth Vis Sci 2009, 50(1): 358-63


Endothelial dysfunction in glaucoma.
Resch H, Garhöfer G, Fuchsjäger-Mayrl G, Hommer A, Schmetterer L: Acta Ophthamlol Scan 2009, 87: 4-12


Estimation of ocular rigidity based on measurement of pulse amplitude using pneumotonometry and fundus pulse using laser interferometry in glaucoma.
Hommer A, Fuchsjäger-Mayrl G, Resch H, Vass C, Garhöfer G, Schmetterer L: Invest Ophth Vis Sci 2008, 49:4046-4050


A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective.
A. Hommer, J. Wickstrøm, M. M. Friis, C. Steeds, J. Thygesen, A. Ferreras, P. Gouws and P. Buchholz: Current Medical Research and Opinion; Vol. 24, No. 4, 2008, 1057–1063


Okuläre Hypertension. Behandeln: Ja oder Nein?
Hommer A., Resch H. Spektrum der Augenheilkunde May 2007, Volume 21, Issue 2, pp 114-117


Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe.
C E Traverso, J G Walt, S P Kelly, A H Hommer, A M Bron, P Denis, J-P Nordmann, J-P Renard, A Bayer, F Grehn, N Pfeiffer, C Cedrone, S Gandolfi, N Orzalesi, C Nucci, L Rossetti, A Azuara-Blanco, A Bagnis, R
Hitchings, J F Salmon, G Bricola, P M Buchholz, S V Kotak, L M Katz, L R Siegartel, J J Doyle: Br J Ophthalmol 2005;89:1245–1249.


So tropft man richtig: European Glaucoma Society und die neuen Guidelines
Hommer A. Spektrum der Augenheilkunde October 2004, Volume 18, Issue 5


100 Jahre Ophthalmologische Gesellschaft in Wien
Gastherausgeber Hommer A., Kaminski S. : Wiener Medizinische Wochenschrift Dezember 2004, Volume 154, Issue 116 Supplement, pp 1-59


100 Jahre Ophthalmologische Gesellschaft in Wien
Gastherausgeber: Anton Hommer, Wien, und Stephan Kaminski, Wien: Wien Med Wochenschr (2004) 154 [Suppl 116]:Springer-Verlag 2004


Travoprost, ein neues Prostaglandin-Analogon zur Glaukombehandlung
Hommer A., Huber-Spitzy V., Kamisnki S. Spektrum der Augenheilkunde February 2002, Volume 16, Issue 1, pp 11-16


Influence of dorzolamide on corneal thickness, endothelial cell count and corneal sensibility
Kaminski S., Hommer A., Koyuncu D., Biowski R., Barisani T., Baumgartner I. Acta Ophthalmologica Scandinavica, Feb. 1998, Vol. 76, Issue1, pp 78-79